TCRX icon

TScan Therapeutics
TCRX

Overview Fund Activity

92 hedge funds and large institutions have $55.4M invested in TScan Therapeutics in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 13 closing their positions.

Holders
92
Holders Change
+3
Holders Change %
+3.37%
% of All Funds
1.25%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
17
Increased
33
Reduced
19
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BI
1
BVF Inc
California
$6.75M
2
TCM
2
Tang Capital Management
California
$828K
3
CC
3
Checkpoint Capital
California
$2.78M
4
Millennium Management
4
Millennium Management
New York
$319K
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$366K

Top Sellers

1
EC
1
EcoR1 Capital
California
$915K
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$0
3
WP
3
Woodline Partners
California
$0
4
DIG
4
Dauntless Investment Group
New Hampshire
$0
5
TAM
5
Tocqueville Asset Management
New York
$37.3K
Name Holding Trade Value Shares
Change 		Shares
Change %
Manulife (Manufacturers Life Insurance)
101
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$44.7K -14,715 Closed
Qube Research & Technologies (QRT)
102
Qube Research & Technologies (QRT)
United Kingdom
– -$44.1K -14,508 Closed
VOYA Investment Management
103
VOYA Investment Management
Georgia
– -$38.9K -12,786 Closed
US Bancorp
104
US Bancorp
Minnesota
– -$6.89K -2,265 Closed
1 2 3 4
5